What dose of ipratropium bromide and albuterol (salbutamol) should be administered to a patient weighing 33.62 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing for 33.62 kg Patient

For a patient weighing 33.62 kg, administer 1.5 mL of the combination ipratropium/albuterol nebulizer solution (containing 0.5 mg ipratropium and 2.5 mg albuterol) every 20 minutes for 3 doses, then as needed.

Rationale

This patient falls into the pediatric dosing category (weight <40 kg, typically children <12 years). The National Asthma Education and Prevention Program (NAEPP) guidelines provide clear weight-based dosing recommendations 1.

Breakdown of the Dosing:

For combination ipratropium/albuterol nebulizer solution:

  • Child dose: 1.5 mL every 20 minutes for 3 doses
  • Each 3 mL vial contains 0.5 mg ipratropium + 2.5 mg albuterol
  • Therefore, 1.5 mL delivers 0.25 mg ipratropium + 1.25 mg albuterol

For adult dosing (≥40 kg or ≥12 years): 3 mL every 20 minutes for 3 doses 1, 2, 1

If Dosing Components Separately:

Albuterol alone:

  • Weight-based: 0.15 mg/kg = 5.04 mg per dose
  • Practical dose: 2.5-5 mg every 20 minutes for 3 doses 1

Ipratropium alone:

  • 0.25-0.5 mg every 20 minutes for 3 doses 1
  • Can be mixed in the same nebulizer with albuterol 1, 3

Clinical Context

When to Add Ipratropium:

Ipratropium should be added to short-acting beta-agonist therapy specifically for severe exacerbations 1. The guidelines emphasize:

  • Not first-line therapy—add to SABA for severe cases
  • Most beneficial in initial 3 hours of severe exacerbations
  • Evidence shows reduced hospitalization rates in severe asthma (37.5% vs 52.6% without ipratropium) 4
  • No additional benefit once patient is hospitalized 1

Severity Assessment:

For patients with severe asthma (peak flow <50% predicted, respiratory rate ≥25/min, heart rate ≥110/min, inability to complete sentences), the combination therapy is indicated 1, 5.

For moderate exacerbations (peak flow 50-70% predicted), ipratropium addition shows minimal benefit 4, 6.

Important Caveats:

  • Timing matters: Give ipratropium with the second and third albuterol doses if not using pre-mixed combination 4
  • Drug stability: If mixing separately, use within 1 hour 3
  • Frequency: Doses should be 6-8 hours apart for maintenance, but every 20 minutes for acute exacerbations 1, 3
  • Corticosteroids: Should be administered concurrently (prednisone 1-2 mg/kg, max 60 mg/day) 1, 4

Side Effect Profile:

The combination is generally well-tolerated, though post-hoc analysis suggests slightly increased palpitations with combination therapy versus albuterol alone 7. This is clinically acceptable given the improved outcomes in severe exacerbations.

Related Questions

For nebulizing an asthma patient, after drawing up 2 ml of ipratropium bromide (Atrovent) and 1 ml of salbutamol (albuterol), how much additional normal saline should be added, if any?
Is Duoneb (ipratropium bromide and albuterol) safe and what dose should be used for a 3‑year‑old child weighing 15 kg?
What is the recommended dosing regimen for nebulized Duoneb (albuterol 2.5 mg + ipratropium bromide 0.5 mg) in adults and in children aged 6 years and older, including initial doses, repeat dosing, and maximum 24‑hour volume?
How should ipratropium (0.25 mg/mL) be diluted for nebulization to obtain a 3 mL volume for an adult 0.5 mg dose and a pediatric 0.25 mg dose, and can albuterol be added or sterile water used if normal saline is unavailable?
What is the brand name Duoneb (albuterol/ipratropium bromide) and the recommended dosage for acute asthma exacerbation?
In a male patient over 65 years old, does aspirin (acetylsalicylic acid) provide any protection against deep vein thrombosis (DVT)?
In a patient 7 months after distal biceps tendon repair who has persistent ante‑cubital numbness and intermittent shooting pain up the arm, should an electromyography (EMG) be performed now?
Can a vitamin be administered intramuscularly to a patient currently receiving antimicrobial therapy for an infection?
What is the appropriate cefdinir (250 mg/5 mL) suspension dose for a child weighing 33.62 kg?
In a patient with chronic kidney disease stage 4 who experienced multiple presyncopal episodes that improved with Trendelenburg positioning and now has an elevated BUN‑creatinine ratio of about 28, what is the appropriate immediate management?
In a 16-year-old who meets diagnostic criteria for ADHD, is a Vanderbilt rating scale still required?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.